DIAMOND STUART received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 7/6/2023ACC: 0001493152-23-023822
Director
Since Aug 2022
+28.39K
Net shares
Net buyer
$56.3K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
28.39K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8.23K
Price / share
$2.28
Trade value
$18.76K
% of position
201.6%
1/1/2023
4.08K→12.31K
Common Stock
Direct
Shares
+9.92K
Price / share
$1.89
Trade value
$18.75K
% of position
80.6%
4/15/2023
12.31K→22.23K
Common Stock
Direct
Shares
+10.24K
Price / share
$1.83
Trade value
$18.75K
% of position
46.1%
7/1/2023
22.23K→32.47K
Total
Net shares
+28.39K
Net value
$56.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2023 | A · Award | +8.23K | $2.28 | $18.76K | 201.6% | 4.08K | 12.31K |
| Common Stock Direct | 4/15/2023 | A · Award | +9.92K | $1.89 | $18.75K | 80.6% | 12.31K | 22.23K |
| Common Stock Direct | 7/1/2023 | A · Award | +10.24K | $1.83 | $18.75K | 46.1% | 22.23K | 32.47K |
| Total | +28.39K | $56.25K | ||||||
Derivative Transactions0
No derivative transactions reported